Welcome to the Life Science Analytics’ Report Center – the number
one resource for up-to-the minute biomedical corporate intelligence.
Tracking over 2500 pharmaceutical, biotechnology and biomedical companies worldwide,
the Life Science Analytics’ Report Center is a first-stop research
store that puts accurate market data and authoritative analysis and information
at your fingertips. The Report Center consolidates all of Life
Science Analytics’ global biomedical company reports into a single easily searchable
online resource, allowing you to find the intelligence that you require quickly
Life Science Analytics has developed a series of reports that provide an unbiased,
accurate, independent approach to company analysis, whether for partnering, investment
or competitive intelligence purposes.
Below is a short summary of the 5 report types that are available to purchase via
the Life Science Analytics’ Report Center:
Competitor Reports provide detailed analysis of a company’s products
by therapeutic indication, a summary of its overall pipeline as well as insight
into the predicted likelihood of clinical success for each pipeline product. Every
Competitor Report compares the company against its primary competitors by individual
& Alliances Reports provide detail on a company’s deals and deal partners.
Each report contains information on size of deals, deals by therapeutic area and
stage of development, product and technology.
Reports contain detailed information on pipelines by phase and therapeutic
indication as well as management information, deals and alliances and recent news
on the company including key milestones.
Global Public & Private Company Pipeline Reports provide up
to date insight into company’s business description, product information, pipeline
details including both summary information and detailed individual product records.
Therapy Area Pipeline Reports contain detailed information
on drug pipelines by therapeutic indication. Each report provides insight into the
pipeline status of a specific therapeutic indication by company and by stage as
well as a summary of the latest news and developments in this area.